(Q55064373)

16 June 2018

reason for preferred rank

title

The in vitro degradation of cisatracurium, the R, cis-R′-isomer of atracurium, in human and rat plasma (English)

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

15 July 2024

The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7648763

15 July 2024

1 reference

R. M. Welch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7648763

15 July 2024

A. Brown

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7648763

15 July 2024

J. Ravitch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7648763

15 July 2024

R. Dahl

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7648763

15 July 2024

language of work or name

English

0 references

publication date

1 August 1995

1 reference

16 June 2018

Clinical Pharmacology & Therapeutics

published in

1 reference

16 June 2018

volume

58

1 reference

16 June 2018

issue

2

1 reference

16 June 2018

page(s)

132-142

1 reference

16 June 2018

In vitro degradation of atracurium in human plasma

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

In vitro degradation of atracurium in human plasma

15 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.

15 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function

15 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds

15 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

The pharmacokinetics of atracurium isomers in vitro and in humans

15 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

Review of atracurium by continuous i.v. infusion

15 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/0009-9236(95)90190-6

15 July 2024

Identifiers

1 reference

16 June 2018

1 reference

16 June 2018